ESSEX BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 1061 for the last semiannual is 811.63 M HKD, and it's 0.55% higher compared to the previous semiannual. The net income of H1 24 is 157.44 M HKD.